September 14, 2020
The Japan arm of AstraZeneca has started discussions with the Pharmaceuticals and Medical Devices Agency (PMDA) on the resumption of a Japanese clinical trial for its novel coronavirus vaccine after a voluntary pause was triggered globally due to an “unexplained...read more